HKSE - Delayed Quote HKD

JBM (Healthcare) Limited (2161.HK)

2.120
0.000
(0.00%)
At close: 4:08:18 PM GMT+8
Currency in HKD All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
648,415
648,415
520,323
406,139
397,158
Cost of Revenue
310,334
310,334
314,814
244,629
198,725
Gross Profit
338,081
338,081
205,509
161,510
198,433
Operating Expense
180,212
180,212
132,647
125,149
149,411
Operating Income
157,869
157,869
72,862
36,361
49,022
Net Non Operating Interest Income Expense
-7,736
-7,736
-7,937
-6,389
-7,234
Pretax Income
164,890
164,890
76,898
30,745
41,681
Tax Provision
27,680
27,680
13,570
7,417
11,062
Net Income Common Stockholders
130,463
130,463
57,093
24,620
22,600
Diluted NI Available to Com Stockholders
130,463
130,463
57,093
24,620
22,600
Basic EPS
0.15
--
0.06
0.03
0.03
Diluted EPS
0.15
--
0.06
0.03
0.03
Basic Average Shares
883,696
--
891,326
893,686
813,981
Diluted Average Shares
883,696
--
891,359
893,686
813,981
Total Operating Income as Reported
174,205
174,205
87,040
38,943
50,276
Total Expenses
490,546
490,546
447,461
369,778
348,136
Net Income from Continuing & Discontinued Operation
130,463
130,463
57,093
24,620
22,600
Normalized Income
126,749.202
126,749.202
49,867.326
24,629.864
22,744.717
Interest Income
762
762
272
18
175
Interest Expense
8,498
8,498
8,209
6,407
7,409
Net Interest Income
-7,736
-7,736
-7,937
-6,389
-7,234
EBIT
173,388
173,388
85,107
37,152
49,090
EBITDA
219,909
219,909
128,739
84,935
92,692
Reconciled Cost of Revenue
310,334
310,334
314,814
244,629
198,725
Reconciled Depreciation
46,521
46,521
43,632
47,783
43,602
Net Income from Continuing Operation Net Minority Interest
130,463
130,463
57,093
24,620
22,600
Total Unusual Items Excluding Goodwill
4,463
4,463
8,774
-13
-197
Total Unusual Items
4,463
4,463
8,774
-13
-197
Normalized EBITDA
215,446
215,446
119,965
84,948
92,889
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
749.202
749.202
1,548.326
-3.136
-52.283
3/31/2021 - 2/5/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

2633.HK Jacobson Pharma Corporation Limited
1.210
0.00%
 
6896.HK Golden Throat Holdings Group Company Limited
5.430
+6.26%
 
0911.HK QIANHAI HEALTH
0.205
0.00%
 
0239.HK PAK FAH YEOW
2.400
0.00%
 
2877.HK China Shineway Pharmaceutical Group Limited
7.150
+0.85%
 
0570.HK TRAD CHI MED
2.130
-0.93%
 
1681.HK CONSUN PHARMA
9.490
-0.84%
 
0867.HK CMS
8.240
+0.73%
 
0512.HK GRAND PHARMA
8.430
+2.93%